Marketing Guide Ulcerative Colitis Study

Marketing Guide Ulcerative Colitis Study

More than 40 percent of patients with moderate to severe ulcerative colitis achieved clinical remission from the debilitating condition after a year of taking an experimental drug developed by Japan’s Takeda Pharmaceutical Co, according to data from a pivotal late-stage trial.

Read full Takeda drug impresses in ulcerative colitis study

Quick Guide to Ulcerative Colitis Symptoms

Marketing Guide Ulcerative Colitis Study Takeda

If you should experience and one of combination of the following symptoms, be sure to consult with your doctor.
• Rectal bleeding (blood and mucus in the stool)
• Rectal urgency (frequent trips to the toilet and urgent need to move the bowels that often cannot be delayed)
• Severe abdominal cramps
• Frequent diarrhea
• Increased intestinal gas
• Persistent fatigue
• Weight loss

Follow us on Facebook